Follow
Tumor heterogeneity
Tumor heterogeneity describes differences between tumors. Tumor heterogeneity can refer to differences between (1) tumors in different patients, (2) cancer cells in an individual patient's tumor, or (3) a primary and metastatic tumor. Understanding the heterogeneity of a tumor can facilitate diagnosis and treatment.
-
MAR 03, 2020Cancer
Research published recently in the Proceedings of the National Academy of Sciences details the development of a new ...Written By: Kathryn DeMuth SullivanFEB 21, 2020Cancer
A team of researchers from Cornell has taken an innovative approach to crack the diversity code of cancer cells. Using a ...Written By: Kathryn DeMuth SullivanAPR 02, 2019Cancer
The primary goals of metastatic breast cancer treatment are to ensure that the patient has the longest survival pos ...Written By: Aleishia Harris-ArnoldDEC 26, 2018Drug Discovery & Development
According to a multi-disciplinary study carried out by the University of Illinois, a compound was found to effectively s ...Written By: Nouran AminNOV 13, 2018Immunology
Pancreatic Cancer is a devastating disease. Fifty-five thousand new patients were diagnosed this year in the United Stat ...Written By: Aleishia Harris-ArnoldSEP 02, 2018Cell & Molecular Biology
New research shows that scientists have to take steps to verify the identity of the cell lines they grow.Written By: Carmen LeitchAPR 16, 2018Cancer
Scientists increasingly see the similarities between the dedifferentiated stem cell and cancer progression process. Res ...Written By: Mauri BrueggemanNOV 29, 2017Drug Discovery & Development
New evidence that chromatin rearranges in a reversible manner in drug resistant cancer cellsWritten By: Courtney SchaalDEC 30, 2016Cancer
A common misconception is that cancer is caused by a single mutation in the genetic code. In many cases, however, the si ...SEP 27, 2016Clinical & Molecular DX
“Come in, Mr. Smith. The computer is ready for your diagnosis now.” This could conceivably be in store for b ...SEP 26, 2016Cancer
A new microfluidic chip can pick out any cancer cell of choice obtained from liquid biopsy to perform single cell analys ...Written By: Futurity (futurity.org)MAY 18, 2016Cancer
Glioblastomas are the most aggressive primary brain tumor in humans. This is a highly diverse group of tumors that can a ...Written By: Cassidy ReichMAR 04, 2015Cancer
New research by market research firm Frost & Sullivan revealed that the increased use of clinical tools such as in vitro ...Written By: Ilene Schneider
MAR 03, 2020
Cancer
Research published recently in the Proceedings of the National Academy of Sciences details the development of a new
...
Written By:
Kathryn DeMuth Sullivan
FEB 21, 2020
Cancer
A team of researchers from Cornell has taken an innovative approach to crack the diversity code of cancer cells. Using a
...
Written By:
Kathryn DeMuth Sullivan
APR 02, 2019
Cancer
The primary goals of metastatic breast cancer treatment are to ensure that the patient has the longest survival pos
...
Written By:
Aleishia Harris-Arnold
DEC 26, 2018
Drug Discovery & Development
According to a multi-disciplinary study carried out by the University of Illinois, a compound was found to effectively s
...
Written By:
Nouran Amin
NOV 13, 2018
Immunology
Pancreatic Cancer is a devastating disease. Fifty-five thousand new patients were diagnosed this year in the United Stat
...
Written By:
Aleishia Harris-Arnold
SEP 02, 2018
Cell & Molecular Biology
New research shows that scientists have to take steps to verify the identity of the cell lines they grow.
Written By:
Carmen Leitch
APR 16, 2018
Cancer
Scientists increasingly see the similarities between the dedifferentiated stem cell and cancer progression process. Res
...
Written By:
Mauri Brueggeman
NOV 29, 2017
Drug Discovery & Development
New evidence that chromatin rearranges in a reversible manner in drug resistant cancer cells
Written By:
Courtney Schaal
DEC 30, 2016
Cancer
A common misconception is that cancer is caused by a single mutation in the genetic code. In many cases, however, the si
...
SEP 27, 2016
Clinical & Molecular DX
“Come in, Mr. Smith. The computer is ready for your diagnosis now.” This could conceivably be in store for b
...
SEP 26, 2016
Cancer
A new microfluidic chip can pick out any cancer cell of choice obtained from liquid biopsy to perform single cell analys
...
Written By:
Futurity (futurity.org)
MAY 18, 2016
Cancer
Glioblastomas are the most aggressive primary brain tumor in humans. This is a highly diverse group of tumors that can a
...
Written By:
Cassidy Reich
MAR 04, 2015
Cancer
New research by market research firm Frost & Sullivan revealed that the increased use of clinical tools such as in vitro
...
Written By:
Ilene Schneider